Works matching DE "GLYCOPYRROLATE"

Results: 371
    1
    2
    3

    A Metabolomic Severity Score for Airflow Obstruction and Emphysema.

    Published in:
    Metabolites (2218-1989), 2022, v. 12, n. 5, p. 368, doi. 10.3390/metabo12050368
    By:
    • Godbole, Suneeta;
    • Labaki, Wassim W.;
    • Pratte, Katherine A.;
    • Hill, Andrew;
    • Moll, Matthew;
    • Hastie, Annette T.;
    • Peters, Stephen P.;
    • Gregory, Andrew;
    • Ortega, Victor E.;
    • DeMeo, Dawn;
    • Cho, Michael H.;
    • Bhatt, Surya P.;
    • Wells, J. Michael;
    • Barjaktarevic, Igor;
    • Stringer, Kathleen A.;
    • Comellas, Alejandro;
    • O'Neal, Wanda;
    • Kechris, Katerina;
    • Bowler, Russell P.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants.

    Published in:
    Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 952, doi. 10.1002/cpdd.702
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Fandozzi, Christine;
    • Panebianco, Deborah;
    • Caro, Luzelena;
    • Wolford, Dennis;
    • Dreyer, Daniel P.;
    • Valesky, Robert;
    • Martinho, Monika;
    • Rizk, Matthew L.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    31

    Pharmacokinetics of Co‐Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed‐Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single‐Dose, Crossover Study in Healthy Adults

    Published in:
    Clinical Pharmacology in Drug Development, 2019, v. 8, n. 2, p. 223, doi. 10.1002/cpdd.585
    By:
    • Maes, Andrea;
    • DePetrillo, Paolo;
    • Siddiqui, Shahid;
    • Reisner, Colin;
    • Dorinsky, Paul
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study.

    Published in:
    CNS Drugs, 2020, v. 34, n. 12, p. 1275, doi. 10.1007/s40263-020-00775-9
    By:
    • Pilo de la Fuente, Belen;
    • Sabín, Julia;
    • Galán, Victoria;
    • Thuissard, Israel;
    • Sainz de la Maza, Susana;
    • Costa-Frossard, Lucienne;
    • Gómez-Moreno, Mayra;
    • Díaz-Díaz, Judit;
    • Oreja-Guevara, Celia;
    • Lozano-Ros, Alberto;
    • García-Domínguez, José M.;
    • Borrego, Laura;
    • Ayuso, Lucía;
    • Castro, Andy;
    • Sánchez, Pedro;
    • Meca-Lallana, Virginia;
    • Muñoz, Carmen;
    • Casanova, Ignacio;
    • López de Silanes, Carlos;
    • Martín, Hugo
    Publication type:
    Article
    38

    Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.

    Published in:
    2020
    By:
    • Naismith, Robert T.;
    • Wundes, Annette;
    • Ziemssen, Tjalf;
    • Jasinska, Elzbieta;
    • Freedman, Mark S.;
    • Lembo, Anthony J.;
    • Selmaj, Krzysztof;
    • Bidollari, Ilda;
    • Chen, Hailu;
    • Hanna, Jerome;
    • Leigh-Pemberton, Richard;
    • Lopez-Bresnahan, Maria;
    • Lyons, Jennifer;
    • Miller, Catherine;
    • Rezendes, David;
    • Wolinsky, Jerry S.;
    • EVOLVE-MS-2 Study Group
    Publication type:
    journal article
    39
    40

    Theraputic options for hyperhidrosis.

    Published in:
    Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2021, v. 12, n. 7, p. 115
    By:
    • Elsayed, Manal Mohamed;
    • Mohammed, Soheir Mohammed Ghonemy;
    • Sheneeb, Najat Hussain Ali
    Publication type:
    Article
    41

    Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.

    Published in:
    Journal of Asthma & Allergy, 2023, v. 16, p. 123, doi. 10.2147/JAA.S392975
    By:
    • van Zyl-Smit, Richard N;
    • Chapman, Kenneth R;
    • Kerstjens, Huib AM;
    • Gessner, Christian;
    • Sagara, Hironori;
    • Tanase, Ana-Maria;
    • Hosoe, Motoi;
    • Pethe, Abhijit;
    • Lawrence, David;
    • Tillmann, Hanns-Christian;
    • D'Andrea, Peter
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.

    Published in:
    2017
    By:
    • Reisner, Colin;
    • Fabbri, Leonardo M;
    • Kerwin, Edward M;
    • Fogarty, Charles;
    • Spangenthal, Selwyn;
    • Rabe, Klaus F;
    • Ferguson, Gary T;
    • Martinez, Fernando J;
    • Donohue, James F;
    • Darken, Patrick;
    • St Rose, Earl;
    • Orevillo, Chad;
    • Strom, Shannon;
    • Fischer, Tracy;
    • Golden, Michael;
    • Dwivedi, Sarvajna
    Publication type:
    journal article
    50